Datavant pulls $652 million first-lien term loan from market

By Sara Rosenberg

New York, March 28 – Datavant (Ciox Health/CT Technologies Intermediate Holdings Inc.) shelved its roughly $652 million first-lien term loan due December 2028, according to a market source.

The term loan had been talked at SOFR plus 425 basis points to 450 bps with an original issue discount of 99 to 99.5 and 101 soft call protection for six months.

UBS Investment Bank, Goldman Sachs Bank USA and Deutsche Bank Securities Inc. were the arrangers on the deal.

Proceeds were going to be used to extend the company’s existing term loan by three years.

Datavant, backed by New Mountain Capital, is an Alpharetta, Ga.-based health care data logistics company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.